Capital Square’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $279K | Buy |
5,944
+50
| +0.8% | +$2.34K | 0.15% | 152 |
|
2025
Q1 | $359K | Buy |
5,894
+44
| +0.8% | +$2.68K | 0.21% | 111 |
|
2024
Q4 | $349K | Buy |
5,850
+8
| +0.1% | +$477 | 0.2% | 121 |
|
2024
Q3 | $302K | Buy |
5,842
+49
| +0.8% | +$2.54K | 0.18% | 120 |
|
2024
Q2 | $247K | Sell |
5,793
-462
| -7% | -$19.7K | 0.16% | 128 |
|
2024
Q1 | $339K | Buy |
6,255
+79
| +1% | +$4.29K | 0.24% | 102 |
|
2023
Q4 | $317K | Sell |
6,176
-134
| -2% | -$6.88K | 0.36% | 74 |
|
2023
Q3 | $359K | Buy |
6,310
+92
| +1% | +$5.23K | 0.48% | 58 |
|
2023
Q2 | $398K | Buy |
6,218
+44
| +0.7% | +$2.81K | 0.37% | 78 |
|
2023
Q1 | $437K | Buy |
6,174
+274
| +5% | +$19.4K | 0.4% | 70 |
|
2022
Q4 | $425K | Sell |
5,900
-138
| -2% | -$9.93K | 0.38% | 76 |
|
2022
Q3 | $429K | Buy |
6,038
+212
| +4% | +$15.1K | 0.39% | 71 |
|
2022
Q2 | $448K | Sell |
5,826
-176
| -3% | -$13.5K | 0.37% | 75 |
|
2022
Q1 | $438K | Sell |
6,002
-138
| -2% | -$10.1K | 0.31% | 90 |
|
2021
Q4 | $381K | Buy |
6,140
+49
| +0.8% | +$3.04K | 0.26% | 99 |
|
2021
Q3 | $362K | Buy |
6,091
+735
| +14% | +$43.7K | 0.26% | 104 |
|
2021
Q2 | $359K | Buy |
5,356
+106
| +2% | +$7.11K | 0.26% | 103 |
|
2021
Q1 | $328K | Buy |
5,250
+1,167
| +29% | +$72.9K | 0.24% | 115 |
|
2020
Q4 | $253K | Sell |
4,083
-453
| -10% | -$28.1K | 0.21% | 123 |
|
2020
Q3 | $273K | Sell |
4,536
-46
| -1% | -$2.77K | 0.28% | 104 |
|
2020
Q2 | $269K | Sell |
4,582
-96
| -2% | -$5.64K | 0.29% | 107 |
|
2020
Q1 | $261K | Buy |
4,678
+79
| +2% | +$4.41K | 0.3% | 93 |
|
2019
Q4 | $295K | Buy |
+4,599
| New | +$295K | 0.28% | 96 |
|